FDA Import Refusal AEK-8354685-1/61/1 — AJANTA PHARMA LTD
The FDA refused shipment AEK-8354685-1/61/1 from AJANTA PHARMA LTD (India) on Mar 21, 2025. The refused product falls under Drugs and Biologics — DAPAGLIFLOZIN (ANTI-DIABETIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Mar 21, 2025
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 61PDA70 DAPAGLIFLOZIN (ANTI-DIABETIC)
- Charges
- 75